tirzepatide trial near me enhances weight loss with sustained treatment but discontinuation leads to weight regain Wrapping up #JACCJournals' #obesity trials

While Ozempic is primarily used to help manage blood sugar levels in people with type 2 diabetes, it has been shown to promote weight loss as a secondary effect

Meta-analysis: antioxidant supplements for liver diseases - the cochrane hepato-biliary group

Zepbound (Tirzepatide): Known for exceptional weight reduction efficacy of up to 20.9% in clinical studies, Zepbound is another once-weekly injectable targeting GLP-1 and GIP receptors

It belongs to a class of medications called glucagon-like peptide-1 (GLP-1) receptor agonists, which were originally developed for type 2 diabetes management but have demonstrated significant efficacy in promoting weight loss

V.SatyanarayanaS

(e.g., RTW, Atlas, Bain Capital Life Sciences) Biotech VCs determine what GLP-1 era 2.0 looks like, and founders should watch them closely because they create long-term infrastructure needs